GO
Loading...
 

Executive Decision: Daniel Junius, IMGN

Tue 26 Feb 13 | 06:45 PM ET
 Highlight transcript below to create clip
Transcript:  Print  |  Email
    This term does not appear
Go
 Click text to jump within video

Executive Decision: Daniel Junius, IMGN

Tue 26 Feb 13 | 06:45 PM ET
Biotech Immunogen showed signs of life today after getting FDA approval of a new breast cancer treatment. Cramer talks to CEO Daniel Junius about the progress of the drug and when patients will see it in doctor's offices, as well as what it means to the company.
 
RELATED ARTICLES AND CONTENT
More Videos
  • No Articles Available
Latest Videos
Luxury rental boom ... in Jersey
Fri 18 Apr 14 | 12:00 PM ET
Latest Videos
Great growth expectations
Fri 18 Apr 14 | 11:00 AM ET
Go
Displaying results for: Latest Video | US